Neuropace Inc (NPCE NASDAQ) stock market data APIs
$9.7986
0.09(0.9%)
as of September 15, 2025
Try our APIs with
free plan!
Neuropace Inc Financial Data Overview
Price chart is built with
Anychart
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data management system; and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Prev. Close
9.7986
Open
9.8928
High
10.1291
Low
9.715
52 wk Range
5.45-18.975
Market Cap
326 M
Shares Outstanding
33 082 K
Revenue
88 570 K
EPS
-0.26
Beta
1.904
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Neuropace Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Neuropace Inc data using free add-ons & libraries
Get Neuropace Inc Fundamental Data
Neuropace Inc Fundamental data includes:
- Net Revenue: 88 570 K
- EBITDA: -19 659 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: -0.22
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Neuropace Inc News
New
3 Stocks Priced Below Estimated Value Offering Opportunities In September 2025
As the Nasdaq Composite reaches new record highs and the Dow Jones Industrial Average experiences a slight dip, investors are closely watching market movements amid anticipation of an interest rate de...
3 Stocks Estimated To Be Trading At Up To 31.8% Below Intrinsic Value
As the U.S. stock market reaches new record highs, buoyed by expectations of potential interest rate cuts and steady inflation data, investors are keenly observing opportunities that may still be unde...
3 Stocks Estimated To Be Trading At Discounts Of Up To 23%
As the U.S. market continues to experience record highs, with indices like the S&P 500 and Nasdaq reaching unprecedented levels, investors are keenly observing economic indicators such as the Producer...
Three Companies That May Be Trading Below Estimated Values In September 2025
As the U.S. markets reach record highs, with major indices like the Dow, S&P 500, and Nasdaq closing at unprecedented levels amid expectations of potential Federal Reserve interest rate cuts, investor...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
